Not a healthcare professional? Go to the patient or caregiver website.

PROSTIN VR®Boxed Warning (alprostadil)

WARNING

Apnea is experienced by about 10 to 12% of neonates with congenital heart defects treated with PROSTIN VR PEDIATRIC Sterile Solution. Apnea is most often seen in neonates weighing less than 2 kg at birth and usually appears during the first hour of drug infusion. Therefore, respiratory status should be monitored throughout treatment, and PROSTIN VR PEDIATRIC should be used where ventilatory assistance is immediately available.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No